Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Kopp

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Molecular Immunology|January 19, 2013
Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditionsLisa M Kopp, Anish Ray, Cecele J Denman, et al.
Pediatric Blood & Cancer|September 2, 2014
Utility of bone marrow aspiration and biopsy in initial staging of Ewing sarcomaLisa M Kopp, Chengcheng Hu, Beatriz Rozo, et al.
Journal of Adolescent and Young Adult Oncology|January 7, 2020
Dietary Interventions for Adult Survivors of Adolescent and Young Adult Cancers: A Systematic Review and Narrative SynthesisMeghan B Skiba, Jennifer J McElfresh, Carol L Howe, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2019
Phase II trial of the glycoprotein non-metastatic B-targeted antibody-drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology GroupLisa M Kopp, Suman Malempati, Mark Krailo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2021
Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology GroupEmma R Lipshultz, Eric J Chow, David R Doody, et al.
Plos One|January 27, 2012
Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cellsCecele J Denman, Vladimir V Senyukov, Srinivas S Somanchi, et al.
Cancer|October 13, 2021
Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology GroupEric J Chow, Richard Aplenc, Lynda M Vrooman, et al.
Cardio-Oncology (London, England)|March 11, 2020
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology GroupLisa M Kopp, Richard B Womer, Cindy L Schwartz, et al.
Cancer|May 12, 2017
Clinical trial enrollment of adolescents and young adults with sarcomaLara E Davis, Katherine A Janeway, Aaron R Weiss, et al.
Journal of Adolescent and Young Adult Oncology|February 1, 2023
Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working GroupSusan L Whiteway, Aaron R Weiss, Safia K Ahmed, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Molecular Immunology|January 19, 2013
Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditionsLisa M Kopp, Anish Ray, Cecele J Denman, et al.
Pediatric Blood & Cancer|September 2, 2014
Utility of bone marrow aspiration and biopsy in initial staging of Ewing sarcomaLisa M Kopp, Chengcheng Hu, Beatriz Rozo, et al.
Journal of Adolescent and Young Adult Oncology|January 7, 2020
Dietary Interventions for Adult Survivors of Adolescent and Young Adult Cancers: A Systematic Review and Narrative SynthesisMeghan B Skiba, Jennifer J McElfresh, Carol L Howe, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2019
Phase II trial of the glycoprotein non-metastatic B-targeted antibody-drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology GroupLisa M Kopp, Suman Malempati, Mark Krailo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2021
Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology GroupEmma R Lipshultz, Eric J Chow, David R Doody, et al.
Plos One|January 27, 2012
Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cellsCecele J Denman, Vladimir V Senyukov, Srinivas S Somanchi, et al.
Cancer|October 13, 2021
Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology GroupEric J Chow, Richard Aplenc, Lynda M Vrooman, et al.
Cardio-Oncology (London, England)|March 11, 2020
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology GroupLisa M Kopp, Richard B Womer, Cindy L Schwartz, et al.
Cancer|May 12, 2017
Clinical trial enrollment of adolescents and young adults with sarcomaLara E Davis, Katherine A Janeway, Aaron R Weiss, et al.
Journal of Adolescent and Young Adult Oncology|February 1, 2023
Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working GroupSusan L Whiteway, Aaron R Weiss, Safia K Ahmed, et al.
Pageof 3